Vericel Corp. (VCEL)
35.13
-1.65
(-4.49%)
USD |
NASDAQ |
May 07, 16:00
35.13
0.00 (0.00%)
After-Hours: 20:00
Vericel SG&A Expense (TTM) : 166.99M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Marker Therapeutics, Inc. | 4.185M |
| Arbutus Biopharma Corp. | 15.89M |
| Tenaya Therapeutics, Inc. | 24.72M |
| Moderna, Inc. | 979.00M |
| Anavex Life Sciences Corp. | 12.80M |